AMAL vs MSDL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMAL presents a dichotomy between strong fundamental value and bearish sentiment. The Piotroski F-Score of 4/9 indicates stable financial health, while the current price of $42.31 sits below both the Graham Number ($45.21) and the growth-based Intrinsic Value ($80.65). Despite consistent earnings beats and a low P/E ratio relative to the sector, the stock is facing significant headwinds from heavy insider selling and a strongly bearish technical trend (10/100).
MSDL presents a classic 'yield trap' profile, characterized by a stable but mediocre Piotroski F-Score of 4/9 and a critical lack of earnings growth. While the stock trades at a discount to book value (P/B 0.74) and below its Graham Number ($25.26), these value metrics are undermined by a catastrophic dividend payout ratio of 142.86% and a 43% year-over-year collapse in earnings. The technical trend is completely bearish (0/100), and the intrinsic value of $9.80 suggests the current price is unsupported by fundamental growth.
Compare Another Pair
Related Comparisons
AMAL vs MSDL: Head-to-Head Comparison
This page compares Amalgamated Financial Corp. (AMAL) and Morgan Stanley Direct Lending Fund (MSDL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.